The Emerging Use of Cannabis in cases of Hyperemesis Gravidarum; A Critical Review
Abstract
There is emerging documentation in both medical journals and social media of American and Canadian women inflicted by hyperemesis gravidarum (HG), reporting beneficial effects of cannabis use on their severe symptoms.
In this review, the risks and benefits of this new therapeutic direction are critically considered. While most professional societies warn pregnant women against the use of cannabis due to potential fetal risks, after 40 years and numerous studies, the fetal risks of cannabis have not been clearly substantiated beyond potential intrauterine growth restriction and prematurity. In contrast, there is new evidence of serious fetal neurodevelopmental risks of HG itself.
A risk: benefit analysis suggests that appropriately- powered studies on the efficacy and fetal safety of cannabis for HG are urgently needed.
Keywords
Full Text:
PDFReferences
Clark SM, Costantine MM, Hankins GD. Review of NVP and HG and early pharmacotherapeutic intervention. Obstet Gynecol Int. 2012;252- 676(10):24
Goyal H, Umesh SinglaU, May E. Role of Cannabis in Digestive Disorder. Eur J Gatroenter Hepatol 2017; 29 (2), 135-143
Mersiades AJ, Tognela A, Haber PS, et al. Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV). BMJ Open. 2018 Sep 12;8(9):e020745. doi: 10.1136/bmjopen-2017-020745.
Amin MR , Ali DW. Pharmacology of Medical Cannabis. Adv Exp Ned Biol 2019; 1162, 151-165
https://www.facebook.com . Accessed June 24, 2019
Roberson EK, Patrick WK, Hurwitz EL Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai. Hawaii J Med Public Health. 2014 Sep;73(9):283-7.
Westfall RE, Janssen PA, Lucas P, Capler R. Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'. Complement Ther Clin Pract. 2006 Feb;12(1):27-33. Epub 2005 Dec 22.
Cohen R, Koren G: The use of cannabis for hyperemesis gravidarum-A report from Motherisk Israel. The Forth Coloqium on Hyperemesis Gravidarum. Amsterdam, Netherland, October 2019.
Sharapova SR, Phillips E, Sirocco K, Kaminski JWet al. Effects of prenatal marijuana exposure on neuropsychological outcomes in children aged 1-11 years: A systematic review. Paediatr Perinat Epidemiol. 2018 Nov;32(6):512-532.
El Marroun H, Bolhuis K, Franken IHA, et al. Preconception and prenatal cannabis use and the risk of behavioral and emotional problems in the offspring. Int J Epidemiol 2019; 48: 287-296
Schmid SM, Lapaire O ,Güth U. Cannabinoid Hyperemesis Syndrome: An Underreported Entity Causing Nausea and Vomiting of Pregnancy. Arch Gynecol Obstetr, 2011; 284 (5), 1095-7
Alaniz V I, Liss J , StickrathE. Hyperemesis Syndrome: A Cause of Refractory Nausea and Vomiting in Pregnancy; Obstetr gynecol,2015; 125 (6), 1484-6
Andrews KH, Bracero LA. Cannabinoid hyperemesis syndrome during pregnancy: A case report. J Reprod Med, 60 (9-10), 430-2
Koren G, Ornoy A, Berkovitch M. Hyperemesis gravidarum-Is it a cause of abnormal fetal brain development? Reprod Toxicol. 2018 Aug;79:84-88
de Groot RH, Stein AD, Jolles J, van Boxtel MP, Blauw GJ, van de Bor M, Lumey L. Prenatal famine exposure and cognition at age 59 years. Int J Epidemiol. 2011 Apr;40(2):327-37.
Xu H, Zhang Z, Li L, Liu J. Early life exposure to China's 1959-61 famine and midlife cognition. Int J Epidemiol. 2017 Nov 7. doi: 10.1093/ije/dyx222.
Metz TD, Stickrath EH. Marijuana use in pregnancy and lactation: a review of the evidence. Am J Obstet Gynecol 2015;213:761–8.
DOI: http://dx.doi.org/10.18103/imr.v6i1.846
Refbacks
- There are currently no refbacks.